Global Encephalitis Vaccine Market Growth 2025-2031
The global Encephalitis Vaccine market size is predicted to grow from US$ 1483 million in 2025 to US$ 2082 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito?s classes. People and many animals may be infection source after infection Encephalitis virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Encephalitis Vaccine Industry Forecast? looks at past sales and reviews total world Encephalitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccine sales for 2025 through 2031. With Encephalitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Encephalitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Encephalitis Vaccine market?
What factors are driving Encephalitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Encephalitis Vaccine market opportunities vary by end market size?
How does Encephalitis Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito?s classes. People and many animals may be infection source after infection Encephalitis virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Encephalitis Vaccine Industry Forecast? looks at past sales and reviews total world Encephalitis Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccine sales for 2025 through 2031. With Encephalitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Encephalitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Inactivated Vaccine
- Live Attenuated Vaccine
- Child
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Valneva
- Sanofi Pasteur
- Biken
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Chengdu Institute of Biological Products
- Tiantan Biological Products
- Liaoning Chengda
- Zhejiang Tianyuan Bio-Pharmaceutical
- Yisheng Bio
- Changchun Institute of Biological Products
What is the 10-year outlook for the global Encephalitis Vaccine market?
What factors are driving Encephalitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Encephalitis Vaccine market opportunities vary by end market size?
How does Encephalitis Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encephalitis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Encephalitis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Encephalitis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Encephalitis Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Encephalitis Vaccine Sales by Type
2.3.1 Global Encephalitis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Encephalitis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Encephalitis Vaccine Sale Price by Type (2020-2025)
2.4 Encephalitis Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Encephalitis Vaccine Sales by Application
2.5.1 Global Encephalitis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Encephalitis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Encephalitis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Encephalitis Vaccine Breakdown Data by Company
3.1.1 Global Encephalitis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Encephalitis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Encephalitis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Encephalitis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Encephalitis Vaccine Sale Price by Company
3.4 Key Manufacturers Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encephalitis Vaccine Product Location Distribution
3.4.2 Players Encephalitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENCEPHALITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Encephalitis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Encephalitis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Encephalitis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Encephalitis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Encephalitis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Encephalitis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Encephalitis Vaccine Sales Growth
4.4 APAC Encephalitis Vaccine Sales Growth
4.5 Europe Encephalitis Vaccine Sales Growth
4.6 Middle East & Africa Encephalitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Encephalitis Vaccine Sales by Country
5.1.1 Americas Encephalitis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Encephalitis Vaccine Revenue by Country (2020-2025)
5.2 Americas Encephalitis Vaccine Sales by Type (2020-2025)
5.3 Americas Encephalitis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encephalitis Vaccine Sales by Region
6.1.1 APAC Encephalitis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Encephalitis Vaccine Revenue by Region (2020-2025)
6.2 APAC Encephalitis Vaccine Sales by Type (2020-2025)
6.3 APAC Encephalitis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Encephalitis Vaccine by Country
7.1.1 Europe Encephalitis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Encephalitis Vaccine Revenue by Country (2020-2025)
7.2 Europe Encephalitis Vaccine Sales by Type (2020-2025)
7.3 Europe Encephalitis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encephalitis Vaccine by Country
8.1.1 Middle East & Africa Encephalitis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Encephalitis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Encephalitis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Encephalitis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccine
10.3 Manufacturing Process Analysis of Encephalitis Vaccine
10.4 Industry Chain Structure of Encephalitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encephalitis Vaccine Distributors
11.3 Encephalitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR ENCEPHALITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Encephalitis Vaccine Market Size Forecast by Region
12.1.1 Global Encephalitis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Encephalitis Vaccine Forecast by Type (2026-2031)
12.7 Global Encephalitis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Valneva
13.1.1 Valneva Company Information
13.1.2 Valneva Encephalitis Vaccine Product Portfolios and Specifications
13.1.3 Valneva Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Valneva Main Business Overview
13.1.5 Valneva Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Encephalitis Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Biken
13.3.1 Biken Company Information
13.3.2 Biken Encephalitis Vaccine Product Portfolios and Specifications
13.3.3 Biken Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biken Main Business Overview
13.3.5 Biken Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Lanzhou Institute of Biological Products
13.5.1 Lanzhou Institute of Biological Products Company Information
13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lanzhou Institute of Biological Products Main Business Overview
13.5.5 Lanzhou Institute of Biological Products Latest Developments
13.6 Chengdu Institute of Biological Products
13.6.1 Chengdu Institute of Biological Products Company Information
13.6.2 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chengdu Institute of Biological Products Main Business Overview
13.6.5 Chengdu Institute of Biological Products Latest Developments
13.7 Tiantan Biological Products
13.7.1 Tiantan Biological Products Company Information
13.7.2 Tiantan Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.7.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tiantan Biological Products Main Business Overview
13.7.5 Tiantan Biological Products Latest Developments
13.8 Liaoning Chengda
13.8.1 Liaoning Chengda Company Information
13.8.2 Liaoning Chengda Encephalitis Vaccine Product Portfolios and Specifications
13.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Liaoning Chengda Main Business Overview
13.8.5 Liaoning Chengda Latest Developments
13.9 Zhejiang Tianyuan Bio-Pharmaceutical
13.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
13.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolios and Specifications
13.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview
13.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13.10 Yisheng Bio
13.10.1 Yisheng Bio Company Information
13.10.2 Yisheng Bio Encephalitis Vaccine Product Portfolios and Specifications
13.10.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yisheng Bio Main Business Overview
13.10.5 Yisheng Bio Latest Developments
13.11 Changchun Institute of Biological Products
13.11.1 Changchun Institute of Biological Products Company Information
13.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Changchun Institute of Biological Products Main Business Overview
13.11.5 Changchun Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encephalitis Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Encephalitis Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Encephalitis Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Encephalitis Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Encephalitis Vaccine Sales by Type
2.3.1 Global Encephalitis Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Encephalitis Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Encephalitis Vaccine Sale Price by Type (2020-2025)
2.4 Encephalitis Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Encephalitis Vaccine Sales by Application
2.5.1 Global Encephalitis Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Encephalitis Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Encephalitis Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Encephalitis Vaccine Breakdown Data by Company
3.1.1 Global Encephalitis Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Encephalitis Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Encephalitis Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Encephalitis Vaccine Revenue by Company (2020-2025)
3.2.2 Global Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Encephalitis Vaccine Sale Price by Company
3.4 Key Manufacturers Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encephalitis Vaccine Product Location Distribution
3.4.2 Players Encephalitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENCEPHALITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Encephalitis Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Encephalitis Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Encephalitis Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Encephalitis Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Encephalitis Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Encephalitis Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Encephalitis Vaccine Sales Growth
4.4 APAC Encephalitis Vaccine Sales Growth
4.5 Europe Encephalitis Vaccine Sales Growth
4.6 Middle East & Africa Encephalitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Encephalitis Vaccine Sales by Country
5.1.1 Americas Encephalitis Vaccine Sales by Country (2020-2025)
5.1.2 Americas Encephalitis Vaccine Revenue by Country (2020-2025)
5.2 Americas Encephalitis Vaccine Sales by Type (2020-2025)
5.3 Americas Encephalitis Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encephalitis Vaccine Sales by Region
6.1.1 APAC Encephalitis Vaccine Sales by Region (2020-2025)
6.1.2 APAC Encephalitis Vaccine Revenue by Region (2020-2025)
6.2 APAC Encephalitis Vaccine Sales by Type (2020-2025)
6.3 APAC Encephalitis Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Encephalitis Vaccine by Country
7.1.1 Europe Encephalitis Vaccine Sales by Country (2020-2025)
7.1.2 Europe Encephalitis Vaccine Revenue by Country (2020-2025)
7.2 Europe Encephalitis Vaccine Sales by Type (2020-2025)
7.3 Europe Encephalitis Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encephalitis Vaccine by Country
8.1.1 Middle East & Africa Encephalitis Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Encephalitis Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Encephalitis Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Encephalitis Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccine
10.3 Manufacturing Process Analysis of Encephalitis Vaccine
10.4 Industry Chain Structure of Encephalitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encephalitis Vaccine Distributors
11.3 Encephalitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR ENCEPHALITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Encephalitis Vaccine Market Size Forecast by Region
12.1.1 Global Encephalitis Vaccine Forecast by Region (2026-2031)
12.1.2 Global Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Encephalitis Vaccine Forecast by Type (2026-2031)
12.7 Global Encephalitis Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Valneva
13.1.1 Valneva Company Information
13.1.2 Valneva Encephalitis Vaccine Product Portfolios and Specifications
13.1.3 Valneva Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Valneva Main Business Overview
13.1.5 Valneva Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Encephalitis Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Biken
13.3.1 Biken Company Information
13.3.2 Biken Encephalitis Vaccine Product Portfolios and Specifications
13.3.3 Biken Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biken Main Business Overview
13.3.5 Biken Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Lanzhou Institute of Biological Products
13.5.1 Lanzhou Institute of Biological Products Company Information
13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lanzhou Institute of Biological Products Main Business Overview
13.5.5 Lanzhou Institute of Biological Products Latest Developments
13.6 Chengdu Institute of Biological Products
13.6.1 Chengdu Institute of Biological Products Company Information
13.6.2 Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chengdu Institute of Biological Products Main Business Overview
13.6.5 Chengdu Institute of Biological Products Latest Developments
13.7 Tiantan Biological Products
13.7.1 Tiantan Biological Products Company Information
13.7.2 Tiantan Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.7.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tiantan Biological Products Main Business Overview
13.7.5 Tiantan Biological Products Latest Developments
13.8 Liaoning Chengda
13.8.1 Liaoning Chengda Company Information
13.8.2 Liaoning Chengda Encephalitis Vaccine Product Portfolios and Specifications
13.8.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Liaoning Chengda Main Business Overview
13.8.5 Liaoning Chengda Latest Developments
13.9 Zhejiang Tianyuan Bio-Pharmaceutical
13.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Information
13.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolios and Specifications
13.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Main Business Overview
13.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13.10 Yisheng Bio
13.10.1 Yisheng Bio Company Information
13.10.2 Yisheng Bio Encephalitis Vaccine Product Portfolios and Specifications
13.10.3 Yisheng Bio Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yisheng Bio Main Business Overview
13.10.5 Yisheng Bio Latest Developments
13.11 Changchun Institute of Biological Products
13.11.1 Changchun Institute of Biological Products Company Information
13.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
13.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Changchun Institute of Biological Products Main Business Overview
13.11.5 Changchun Institute of Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Encephalitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 6. Global Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Encephalitis Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Encephalitis Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Encephalitis Vaccine Sale by Application (2020-2025) & (Units)
Table 11. Global Encephalitis Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Encephalitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Encephalitis Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Encephalitis Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Encephalitis Vaccine Sales by Company (2020-2025) & (Units)
Table 16. Global Encephalitis Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Encephalitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Encephalitis Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Encephalitis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Encephalitis Vaccine Products Offered
Table 22. Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Encephalitis Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Encephalitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Encephalitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Encephalitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Encephalitis Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Encephalitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Encephalitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Encephalitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 34. Americas Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 37. Americas Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 38. APAC Encephalitis Vaccine Sales by Region (2020-2025) & (Units)
Table 39. APAC Encephalitis Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Encephalitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 42. APAC Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 43. Europe Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 44. Europe Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 46. Europe Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Encephalitis Vaccine
Table 52. Key Market Challenges & Risks of Encephalitis Vaccine
Table 53. Key Industry Trends of Encephalitis Vaccine
Table 54. Encephalitis Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Encephalitis Vaccine Distributors List
Table 57. Encephalitis Vaccine Customer List
Table 58. Global Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global Encephalitis Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas Encephalitis Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Encephalitis Vaccine Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global Encephalitis Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Encephalitis Vaccine Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global Encephalitis Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Valneva Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Valneva Encephalitis Vaccine Product Portfolios and Specifications
Table 74. Valneva Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Valneva Main Business
Table 76. Valneva Latest Developments
Table 77. Sanofi Pasteur Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur Encephalitis Vaccine Product Portfolios and Specifications
Table 79. Sanofi Pasteur Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Biken Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Biken Encephalitis Vaccine Product Portfolios and Specifications
Table 84. Biken Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Biken Main Business
Table 86. Biken Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lanzhou Institute of Biological Products Main Business
Table 96. Lanzhou Institute of Biological Products Latest Developments
Table 97. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 99. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Chengdu Institute of Biological Products Main Business
Table 101. Chengdu Institute of Biological Products Latest Developments
Table 102. Tiantan Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Tiantan Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 104. Tiantan Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Tiantan Biological Products Main Business
Table 106. Tiantan Biological Products Latest Developments
Table 107. Liaoning Chengda Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Liaoning Chengda Encephalitis Vaccine Product Portfolios and Specifications
Table 109. Liaoning Chengda Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Liaoning Chengda Main Business
Table 111. Liaoning Chengda Latest Developments
Table 112. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolios and Specifications
Table 114. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 116. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 117. Yisheng Bio Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Yisheng Bio Encephalitis Vaccine Product Portfolios and Specifications
Table 119. Yisheng Bio Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Yisheng Bio Main Business
Table 121. Yisheng Bio Latest Developments
Table 122. Changchun Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 124. Changchun Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Changchun Institute of Biological Products Main Business
Table 126. Changchun Institute of Biological Products Latest Developments
Table 1. Encephalitis Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Encephalitis Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 6. Global Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Encephalitis Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Encephalitis Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Encephalitis Vaccine Sale by Application (2020-2025) & (Units)
Table 11. Global Encephalitis Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Encephalitis Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Encephalitis Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Encephalitis Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Encephalitis Vaccine Sales by Company (2020-2025) & (Units)
Table 16. Global Encephalitis Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Encephalitis Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Encephalitis Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Encephalitis Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Encephalitis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Encephalitis Vaccine Products Offered
Table 22. Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Encephalitis Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global Encephalitis Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Encephalitis Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Encephalitis Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Encephalitis Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 30. Global Encephalitis Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Encephalitis Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Encephalitis Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 34. Americas Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 37. Americas Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 38. APAC Encephalitis Vaccine Sales by Region (2020-2025) & (Units)
Table 39. APAC Encephalitis Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Encephalitis Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 42. APAC Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 43. Europe Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 44. Europe Encephalitis Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 46. Europe Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa Encephalitis Vaccine Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Encephalitis Vaccine Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa Encephalitis Vaccine Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of Encephalitis Vaccine
Table 52. Key Market Challenges & Risks of Encephalitis Vaccine
Table 53. Key Industry Trends of Encephalitis Vaccine
Table 54. Encephalitis Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Encephalitis Vaccine Distributors List
Table 57. Encephalitis Vaccine Customer List
Table 58. Global Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global Encephalitis Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas Encephalitis Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Encephalitis Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC Encephalitis Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Encephalitis Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa Encephalitis Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Encephalitis Vaccine Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global Encephalitis Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Encephalitis Vaccine Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global Encephalitis Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Valneva Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Valneva Encephalitis Vaccine Product Portfolios and Specifications
Table 74. Valneva Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Valneva Main Business
Table 76. Valneva Latest Developments
Table 77. Sanofi Pasteur Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Pasteur Encephalitis Vaccine Product Portfolios and Specifications
Table 79. Sanofi Pasteur Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Pasteur Main Business
Table 81. Sanofi Pasteur Latest Developments
Table 82. Biken Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Biken Encephalitis Vaccine Product Portfolios and Specifications
Table 84. Biken Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Biken Main Business
Table 86. Biken Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lanzhou Institute of Biological Products Main Business
Table 96. Lanzhou Institute of Biological Products Latest Developments
Table 97. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Chengdu Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 99. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Chengdu Institute of Biological Products Main Business
Table 101. Chengdu Institute of Biological Products Latest Developments
Table 102. Tiantan Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Tiantan Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 104. Tiantan Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Tiantan Biological Products Main Business
Table 106. Tiantan Biological Products Latest Developments
Table 107. Liaoning Chengda Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Liaoning Chengda Encephalitis Vaccine Product Portfolios and Specifications
Table 109. Liaoning Chengda Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Liaoning Chengda Main Business
Table 111. Liaoning Chengda Latest Developments
Table 112. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product Portfolios and Specifications
Table 114. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 116. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 117. Yisheng Bio Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Yisheng Bio Encephalitis Vaccine Product Portfolios and Specifications
Table 119. Yisheng Bio Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Yisheng Bio Main Business
Table 121. Yisheng Bio Latest Developments
Table 122. Changchun Institute of Biological Products Basic Information, Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Changchun Institute of Biological Products Encephalitis Vaccine Product Portfolios and Specifications
Table 124. Changchun Institute of Biological Products Encephalitis Vaccine Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Changchun Institute of Biological Products Main Business
Table 126. Changchun Institute of Biological Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of Encephalitis Vaccine
Figure 2. Encephalitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encephalitis Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Encephalitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Encephalitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Encephalitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Encephalitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Live Attenuated Vaccine
Figure 13. Global Encephalitis Vaccine Sales Market Share by Type in 2025
Figure 14. Global Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Encephalitis Vaccine Consumed in Child
Figure 16. Global Encephalitis Vaccine Market: Child (2020-2025) & (Units)
Figure 17. Encephalitis Vaccine Consumed in Adult
Figure 18. Global Encephalitis Vaccine Market: Adult (2020-2025) & (Units)
Figure 19. Global Encephalitis Vaccine Sale Market Share by Application (2024)
Figure 20. Global Encephalitis Vaccine Revenue Market Share by Application in 2025
Figure 21. Encephalitis Vaccine Sales by Company in 2025 (Units)
Figure 22. Global Encephalitis Vaccine Sales Market Share by Company in 2025
Figure 23. Encephalitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Encephalitis Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Encephalitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Encephalitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 28. Americas Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 30. APAC Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 32. Europe Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 34. Middle East & Africa Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Americas Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Encephalitis Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Encephalitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 46. APAC Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 57. Europe Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Encephalitis Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Encephalitis Vaccine
Figure 73. Industry Chain Structure of Encephalitis Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Encephalitis Vaccine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Encephalitis Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Encephalitis Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Encephalitis Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Encephalitis Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Encephalitis Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Encephalitis Vaccine
Figure 2. Encephalitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encephalitis Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Encephalitis Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Encephalitis Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Encephalitis Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Encephalitis Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Inactivated Vaccine
Figure 12. Product Picture of Live Attenuated Vaccine
Figure 13. Global Encephalitis Vaccine Sales Market Share by Type in 2025
Figure 14. Global Encephalitis Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Encephalitis Vaccine Consumed in Child
Figure 16. Global Encephalitis Vaccine Market: Child (2020-2025) & (Units)
Figure 17. Encephalitis Vaccine Consumed in Adult
Figure 18. Global Encephalitis Vaccine Market: Adult (2020-2025) & (Units)
Figure 19. Global Encephalitis Vaccine Sale Market Share by Application (2024)
Figure 20. Global Encephalitis Vaccine Revenue Market Share by Application in 2025
Figure 21. Encephalitis Vaccine Sales by Company in 2025 (Units)
Figure 22. Global Encephalitis Vaccine Sales Market Share by Company in 2025
Figure 23. Encephalitis Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Encephalitis Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Encephalitis Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Encephalitis Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 28. Americas Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 30. APAC Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 32. Europe Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Encephalitis Vaccine Sales 2020-2025 (Units)
Figure 34. Middle East & Africa Encephalitis Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Americas Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Encephalitis Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Encephalitis Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 46. APAC Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Encephalitis Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Encephalitis Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 57. Europe Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Encephalitis Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Encephalitis Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Encephalitis Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Encephalitis Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Encephalitis Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Encephalitis Vaccine
Figure 73. Industry Chain Structure of Encephalitis Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Encephalitis Vaccine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Encephalitis Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Encephalitis Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Encephalitis Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Encephalitis Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Encephalitis Vaccine Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Endovenous Laser Ablation Market Growth 2023-2029
US$ 3,660.00
March 2023
96 pages
Global Bone Harvesting System Market Growth 2024-2030
US$ 3,660.00
March 2024
86 pages
Global Meniere Disease Medication Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
95 pages
Global Amblyopia Therapeutic Apparatus Market Growth 2025-2031
US$ 3,660.00
December 2024
95 pages
Global Veno-Venous Extracorporeal Life Support (VV ECLS) Devices Market Growth 2024-2030
US$ 3,660.00
September 2024
87 pages
